127477-09-2Relevant academic research and scientific papers
Condensed pyrazole 3-oxo-propanenitrile derivatives
-
, (2008/06/13)
Condensed pyrazole 3-oxo-propanenitrile derivatives of formula (I) STR1 wherein X represents a --CH(R4)-- group, an oxygen atom or a --S(O)n -- group where n is 0, 1 or 2; R1 represents C1 -C6 alkyl,
Heteroaryl-3-oxo-propanenitrile derivatives useful in the treatment of rheumatoid arthritis and other autoimmune diseases
-
, (2008/06/13)
Heteroaryl-3-oxo-propanenitrile derivatives of formula (I) STR1 wherein X represents an oxygen atom or a --CH(R4)--, --O--CH(R4)--, --S(O)n --CH(R4)--, --CH(R4)--O--, --CH(R4)--S(O)n -- --CH(R4)--CH2 -- group wherein n is 0, 1 or 2; R1 represents C1 -C6 alkyl, pyridyl or unsubstituted or substituted phenyl; R2, R3, and R4 are as herein defined; and Q is hydrogen, carboxy, C2 -C7 -alkoxycarbonyl or a --CON(Ra)Rb group, Ra and Rb being as defined herein; and their pharmaceutically acceptable salts are useful in the preparation of pharmaceutical compositions active in the treatment of autoimmune diseases.
Use of heteroaryl-3-oxo-propanenitrile derivatives in treating clinical wherein myelopoiesis suppression occurs
-
, (2008/06/13)
Heteroaryl-3-oxo-propanenitrile derivatives of formula (I) STR1 wherein X represents an oxygen atom or a --CH(R4)--, --O--CH(R4)--,--S(O)n --, --S(O)n --CH(R4)--, --CH(R4)--O--, --CH(R4)--S(O)n -- or --CH(R4)--CH2 -- group wherein n is 0, 1 or 2; R1 represents C1 --C6 alkyl, pyridyl or unsubstituted or substituted phenyl; R2, R3 and R4 are as herein defined; and Q is hydrogen, carboxy, C2 -C7 - alkoxycarbonyl or a --CON(Ra)Rb group, Ra and Rb being as defined herein; and their pharmaceutically acceptable salts are useful in stimulating myelopoiesis in bone marrow suppressed mammals.
